Prof Yoshiya Tanaka on strategic treatment of psoriatic arthritis patients episode artwork

EPISODE · Jul 2, 2018 · 6 MIN

Prof Yoshiya Tanaka on strategic treatment of psoriatic arthritis patients

from The Rheumatology Podcast · host Oxford University Press

Dr Marwan Bukhari speaks to Prof Yoshiya Tanaka, University of Occupational and Environmental Health, Japan, about his recent paper on strategic treatment of PsA patients according to phenotypic differences in helper T cells. They highlight the benefits of using precision medicine to treat PsA, with significantly higher efficacy observed in this study than in standard bDMARD therapy. They discuss the potential next steps for precision medicine in other diseases and new drugs becoming available for treatment.

Episode metadata supplied by the publisher feed · Published Jul 2, 2018

Embed this episode

Dr Marwan Bukhari speaks to Prof Yoshiya Tanaka, University of Occupational and Environmental Health, Japan, about his recent paper on strategic treatment of PsA patients according to phenotypic differences in helper T cells.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Prof Yoshiya Tanaka on strategic treatment of psoriatic arthritis patients

0:00 6:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Rheumatology Podcast?

This episode is 6 minutes long.

When was this The Rheumatology Podcast episode published?

This episode was published on July 2, 2018.

Can I download this The Rheumatology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!